Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications. Pomdoctor's operations largely encompass both a virtual hospital model and a comprehensive pharmaceutical…
$POM .80 - $5 we like GLXG with that cash horde https://t.co/8NkWawP4QG
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $59.96M | +16.74% | $-31.87M |
| 2024 | $51.36M | +12.37% | $-21.49M |
| 2023 | $45.71M | +24.32% | $-21.8M |
Stock data for POM: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics